Savara Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for SVRA, updated each market day.
SVRA AI Sentiment
AI predicts Savara Inc. stock is likely to decrease over the next 10 market days.
Prediction date: Oct. 9, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Sector
Exchange
Market Cap
$992,371,872
Cap Tier
Employees
70
Headquarters
AUSTIN, TX
Listed Since
Nov. 18, 1996
Website
SVRA Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
SVRA Volatility
Savara Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
